Corbus Pharmaceuticals Holdings

CRBP

$4.00

Name : Corbus Pharmaceuticals Holdings

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $82,427,040.00

EPSttm : -6.04

Corbus Pharmaceuticals Holdings

$4.00

1.78%

$0.07

CRBP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

15.64

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

0.43

EPS Last/This Y

0.3

EPS This/Next Y

0.05

Price

3.95

Target Price

32.83

Analyst Recom

Performance Q

-59.73

Upside

-3,509.2%

Beta

2.81

Ticker: CRBP

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	CRBP	5.26	0.34	0.00	47615
2026-10-13	CRBP	4.78	0.34	0.05	47674
2026-10-14	CRBP	4.41	0.33	0.65	47811
2026-10-15	CRBP	4.32	0.33	52.94	47834
2026-10-16	CRBP	4.51	0.60	0.34	57533
2026-10-19	CRBP	4.46	0.64	0.00	50431
2026-10-20	CRBP	4.41	0.64	0.00	50447
2026-10-21	CRBP	4.28	0.64	0.22	50476
2026-10-22	CRBP	4.13	0.64	0.02	50622
2026-10-23	CRBP	4.04	0.63	0.02	50667
2026-10-26	CRBP	3.99	0.63	0.00	50789
2026-10-27	CRBP	4.14	0.63	0.00	50789
2026-10-28	CRBP	4.27	0.63	0.02	50673
2026-10-29	CRBP	4.23	0.64	1.06	50482
2026-10-30	CRBP	4.22	0.64	0.10	50694
2026-11-02	CRBP	3.92	0.63	0.43	51024
2026-11-03	CRBP	3.87	0.63	0.00	51111
2026-11-04	CRBP	3.57	0.63	0.69	51198
2026-11-05	CRBP	2.85	0.63	2.82	51293
2026-11-06	CRBP	3.07	0.63	18.67	51312
2026-11-09	CRBP	3.53	0.61	1.02	50745
2026-11-10	CRBP	3.97	0.61	0.00	50938
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	CRBP	5.27	36.1	-	-5.43
2026-10-13	CRBP	4.76	36.1	-	-5.43
2026-10-14	CRBP	4.41	36.1	-	-5.43
2026-10-15	CRBP	4.32	36.1	-	-5.43
2026-10-16	CRBP	4.52	36.1	-	-5.43
2026-10-19	CRBP	4.47	36.1	-	-5.43
2026-10-20	CRBP	4.47	36.1	-	-5.43
2026-10-21	CRBP	4.43	36.1	-	-5.43
2026-10-22	CRBP	4.14	36.1	-	-5.43
2026-10-23	CRBP	4.05	36.1	-	-5.43
2026-10-26	CRBP	3.99	36.1	-	-5.43
2026-10-27	CRBP	4.15	36.1	-	-5.43
2026-10-28	CRBP	4.27	36.1	-	-5.43
2026-10-29	CRBP	4.23	36.1	-	-5.43
2026-10-30	CRBP	4.23	36.1	-	-5.43
2026-11-02	CRBP	3.91	33.1	-	-5.60
2026-11-03	CRBP	3.87	33.1	-	-5.60
2026-11-04	CRBP	3.59	33.1	-	-5.60
2026-11-05	CRBP	2.84	33.1	-	-5.60
2026-11-06	CRBP	3.06	33.1	-	-5.60
2026-11-09	CRBP	3.54	33.1	-	-5.60
2026-11-10	CRBP	3.95	33.1	-	-5.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	CRBP	-1.21	4.80	17.60
2026-10-13	CRBP	-1.21	4.80	17.60
2026-10-14	CRBP	-1.21	4.80	17.60
2026-10-15	CRBP	-1.21	4.80	17.60
2026-10-16	CRBP	-1.21	4.80	17.60
2026-10-19	CRBP	-1.21	4.37	17.60
2026-10-20	CRBP	-1.21	4.37	17.60
2026-10-21	CRBP	-1.21	4.37	17.60
2026-10-22	CRBP	-1.21	4.37	17.60
2026-10-23	CRBP	-1.21	4.37	17.60
2026-10-26	CRBP	-1.21	4.19	17.60
2026-10-27	CRBP	-1.21	4.19	15.64
2026-10-28	CRBP	-1.21	4.19	15.64
2026-10-29	CRBP	-1.21	4.19	15.64
2026-10-30	CRBP	-1.21	4.19	15.64
2026-11-02	CRBP	-1.21	4.15	15.64
2026-11-03	CRBP	-18.51	4.15	15.64
2026-11-05	CRBP	-18.52	4.15	15.64
2026-11-06	CRBP	-18.51	4.15	15.64
2026-11-09	CRBP	-18.51	-2.72	15.64
2026-11-10	CRBP	-18.51	-2.72	15.64
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.81

Avg. EPS Est. Current Quarter

-1.27

Avg. EPS Est. Next Quarter

-1.38

Insider Transactions

-18.51

Institutional Transactions

-2.72

Beta

2.81

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.6

Max Drawdown 5-Year %

-95.4

Target Price

32.83

P/E

Forward P/E

PEG

P/S

P/B

0.96

P/Free Cash Flow

EPS

-6.09

Average EPS Est. Cur. Y

-5.6

EPS Next Y. (Est.)

-5.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.61

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.16

EBIT Estimation

◆ CRBP Healthcare

$3.93

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

12/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

6/10

RSI

Range 1M

40.5%

Sup Dist

19.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

8/30

Estimates

0/20

Inst/Vol

0/15

Options

6/10

EPS Yr

EPS NY

9.8%

52W%

10.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +735.4% upside

Quality

2/30

Valuation

16/30

Growth

5/25

Stability

7/10

LT Trend

1/5

Upside

+735.4%

Quality

CRBP — P/E HistoricalBiotechnology

Corbus Pharmaceuticals Holdings

Sector: Healthcare

Industry: Biotechnology

Employees: 36

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

CRBP

Latest News

—

Caricamento notizie per CRBP…

stock quote shares CRBP – Corbus Pharmaceuticals Holdings, Inc. Stock Price stock today

news today CRBP – Corbus Pharmaceuticals Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRBP – Corbus Pharmaceuticals Holdings, Inc. yahoo finance google finance

stock history CRBP – Corbus Pharmaceuticals Holdings, Inc. invest stock market

stock prices CRBP premarket after hours

ticker CRBP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CRBP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y